Terconazole
Product Images NDC 21695-844

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Terconazole (NDC 21695-844). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Instruction 1 (5527cd23 567b 4019 8e5c F71ee7ed2689 01)

FDA Label Image

Instruction 2 (5527cd23 567b 4019 8e5c F71ee7ed2689 02)

FDA Label Image

Instruction 3 (5527cd23 567b 4019 8e5c F71ee7ed2689 03)

FDA Label Image

Instruction 4 (5527cd23 567b 4019 8e5c F71ee7ed2689 04)

FDA Label Image

Instruction 5 (5527cd23 567b 4019 8e5c F71ee7ed2689 05)

FDA Label Image

Terconazole Vaginal 0.4% (5527cd23 567b 4019 8e5c F71ee7ed2689 06)

Terconazole Vaginal 0.4% is a prescription cream used for the treatment of vaginal yeast infections. It is available in a 45 gm tube for a 7-day treatment course with an NDC code 21695-844-45. The manufacturer is Taro Pharmaceuticals in Brampton, Canada, and the product should be stored at a controlled room temperature between 59°-86°F. The lot number is 00000, and the expiration date is 00/00/00. The cream should be used as directed by a physician and should be kept out of reach of children. The package insert provides detailed information on the cream's use, and the product is only available with a prescription.*

FDA Label Image

Chemical Structure (5527cd23 567b 4019 8e5c F71ee7ed2689 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.